Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CNR1 gene and risk of the metabolic syndrome in patients with schizophrenia.

Journal of clinical psychopharmacology - 1 Apr 2013

Yu Weiping, De Hert Marc, Moons Tim, Claes Stephan J, Correll Christoph U, van Winkel Ruud

Abstract excerpt

Metabolic disturbances are more prevalent in patients with schizophrenia (SCZ) than in the general population. The endocannabinoid system plays an important role in the regulation of dopamine transmission and several metabolic pathways, and the endocannabinoid receptor type 1 gene (CNR1) is considered a candidate gene for both SCZ and metabolic disorders. We examined whether genetic variation in CNR1 was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antipsychotic Agents
Share to Cholesterol, HDL

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cross-Sectional Studies

Share to Glucose

Share to Metabolic Syndrome

Share to Prevalence

Share to Receptor, Cannabinoid, CB1

Share to Schizophrenia

Source

Identifiers

PMID: 23422373
DOI: 10.1097/JCP.0b013e318283925e

Genes

CNR1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CNR1 gene and risk of the metabolic syndrome in patients with schizophrenia.PMID 23422373Read ↗

A systematic review of genetic variants associated with metabolic syndrome in patients with schizophrenia.Semantic proximity Read ↗

NOS1AP Gene Variants and Their Role in Metabolic Syndrome: A Study of Patients with SchizophreniaSemantic proximity Read ↗

Complement 3 and metabolic syndrome induced by clozapine: a cross-sectional study and retrospective cohort analysis.Semantic proximity Read ↗

Association between HTR2C polymorphisms and metabolic syndrome in patients with schizophrenia treated with atypical antipsychotics.Semantic proximity Read ↗

Genome Wide Association Study (GWAS) Identifies Novel Genetic Loci for Second-Generation Antipsychotics (SGA)-Induced Metabolic Syndrome (MetS).Semantic proximity Read ↗

Genetic predisposition and antipsychotic treatment effect on metabolic syndrome in schizophrenia: a ten-year follow-up study using the Estonian BiobankSemantic proximity Read ↗

HTR2C polymorphisms, olanzapine-induced weight gain and antipsychotic-induced metabolic syndrome in schizophrenia patients: a meta-analysis.Semantic proximity Read ↗

Metabolic syndrome in patients taking clozapine: prevalence and influence of catechol-O-methyltransferase genotype.Semantic proximity Read ↗

Genome-wide associations with metabolic syndrome among UK Biobank participants reporting use of second-generation antipsychotics.Semantic proximity Read ↗

Polymorphisms in NR3C1 gene associated with risk of metabolic syndrome in a Chinese population.Semantic proximity Read ↗

Association between HTR2C gene polymorphisms and the metabolic syndrome in patients using antipsychotics: a replication study.Semantic proximity Read ↗

Cross-population validation of European GWAS loci for metabolic syndrome in Chinese schizophrenia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.